Exploring the mechanism of lncRNA-BC200 in regulating neuronal injury repair based on controlling BACE1 ubiquitination.
- Author:
Lijun LIU
1
;
Jie DU
2
,
3
;
Huan LIU
1
;
Yuan WANG
1
;
Jing ZHANG
4
Author Information
1. Department of Neurology, Xianning Central Hospital (First Hospital Affiliated to Hubei University of Science and Technology), Xianning 437100, China.
2. Department of Neurology, Xianning Central Hospital (First Hospital Affiliated to Hubei University of Science and Technology), Xianning 437100, China. *Corresponding author, E-mail: daeyxonlc@
3. com.
4. Department of Neurology, Xianning First People's Hospital, Xianning 437000, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Amyloid Precursor Protein Secretases/genetics*;
RNA, Long Noncoding/physiology*;
Aspartic Acid Endopeptidases/genetics*;
Male;
Neurons/pathology*;
Mice;
Mice, Inbred C57BL;
Apoptosis/genetics*;
Ubiquitination;
Cell Line;
Hippocampus/metabolism*;
bcl-2-Associated X Protein/genetics*;
Caspase 3/genetics*;
Infarction, Middle Cerebral Artery/metabolism*
- From:
Chinese Journal of Cellular and Molecular Immunology
2025;41(2):125-133
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the mechanism of lncRNA-BC200 (BC200) targeting the ubiquitination of Beta-site APP cleaving enzyme 1 (BACE1) and regulating the repair of nerve cell injury. Methods Mouse hippocampal neuron cell line HT22 was divided into four groups: control group, oxygen-glucose deprivation/reoxygenation(OGD/R) group, OGD/R+si-NC group and OGD/R+si-BC200 group. In order to further explore the relationship between BC200 and BACE1, HT22 cells were divided into four groups: OGD/R group, OGD/R+si-BC200 group, OGD/R+si-BC200+NC group and OGD/R+si-BC200+ BACE1 group. Twenty male C57BL/6J mice were randomly assigned to the following four groups: control group, middle cerebral artery occlusion (MCAO) group, MCAO+si-BC200 group and MCAO+si-BC200+BACE1 group. The mRNA expression levels of BC200 and BACE1 in cells were measured by real-time quantitative reverse transcription polymerase chain reaction. The expressions of c-caspase-3, B-cell lymphoma 2 (Bcl2), Bcl2 associated X protein(BAX) and BACE1 were detected by western blot, and the apoptotic cells were detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) test. Results Compared with the control group, the activity of HT22 cells in OGD/R group decreased significantly, and the percentage of apoptotic cells increased significantly. Compared with OGD/R+si-NC group, the activity of HT22 cells in OGD/R+si-BC200 group increased significantly, and the percentage of apoptotic cells decreased significantly. Compared with the control group, the expression of BACE1 protein in HT22 cells in OGD/R group was significantly enhanced. Compared with OGD/R+si-NC group, the expression of BACE1 protein in HT22 cells in OGD/R+si-BC200 group decreased significantly. It was observed that after OGD/R treatment, the ubiquitination level of BACE1 decreased significantly and the expression of BACE1 protein increased significantly. After transfection with si-BC200, the ubiquitination level of BACE1 protein increased significantly, while the expression of BACE1 protein decreased significantly. Compared with OGD/R+si-BC200+NC group, the percentage of apoptotic cells, the expression of c-caspase-3 and Bax protein in HT22 cells in OGD/R+si-BC200+BACE1 group increased significantly, and the expression of Bcl2 protein decreased significantly. Compared with the control group, the number of cerebral infarction areas and TUNEL positive cells in MCAO group increased significantly, and the survival number of neurons decreased significantly. Compared with the MCAO group, the number of cerebral infarction areas and TUNEL positive cells in MCAO+si-BC200 group decreased significantly, and the survival number of neurons increased significantly, while the addition of BACE1 reversed the improvement of si-BC200 transfection. Conclusion The combination of BC200 and BACE1 inhibit the ubiquitination of BACE1, and participate in mediating the expression enhancement of BACE1 induced by OGD/R. Specific blocking of BC200/BACE1 axis may be a potential therapeutic target to protect neurons from apoptosis induced by cerebral ischemia/reperfusion.
